<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Diuretics</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top">Diuretic-induced sodium loss may reduce lithium clearance and increase serum lithium concentrations<content stylecode="italics">.</content> </td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> More frequent monitoring of serum electrolyte and lithium concentrations. Reduce lithium dosage based on serum lithium concentration and clinical response <content stylecode="italics">[see Dosage and Administration (2.6), Warning and Precautions (5.3)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> hydrochlorothiazide, chlorothiazide, furosemide</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Non-Steroidal Anti-inflammatory Drugs (NSAID)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> NSAID decrease renal blood flow, resulting in decreased renal clearance and increased serum lithium concentrations.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> More frequent serum lithium concentration monitoring. Reduce lithium dosage based on serum lithium concentration and clinical response <content stylecode="italics">[see Dosage and Administration (2.6)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> indomethacin, ibuprofen, naproxen</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Renin-Angiotensin System Antagonists</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use increase steady-state serum lithium concentrations.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> More frequent monitoring of serum lithium concentration. Reduce lithium dosage based on serum lithium concentration and clinical response <content stylecode="italics">[see Dosage and Administration (2.6)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> lisinopril, enalapril, captopril, valsartan</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Serotonergic Drugs</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use can precipitate serotonin syndrome.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor patients for signs and symptoms of serotonin syndrome, particularly during lithium initiation. If serotonin syndrome occurs, consider discontinuation of lithium and/or concomitant serotonergic drugs <content stylecode="italics">[see Warnings and Precautions (5.6)]</content>.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> selective serotonin reuptake inhibitors (SSRI), serotonin and norepinephrine reuptake inhibitors (SNRI), monoamine oxidase inhibitors (MAOI)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Nitroimidazole Antibiotics</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use may cause lithium toxicity due to reduced renal clearance.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> More frequent monitoring of serum lithium concentration. Reduce lithium dosage based on serum lithium concentration and clinical response <content stylecode="italics">[see Dosage and Administration (2.6)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> metronidazole</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Acetazolamide, Urea, Xanthine Preparations, Alkalinizing Agents</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use can lower serum lithium concentrations by increasing urinary lithium excretion.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> More frequent serum lithium concentration monitoring. Increase lithium dosage based on serum lithium concentration and clinical response <content stylecode="italics">[see Dosage and Administration (2.6)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> acetazolamide, theophylline, sodium bicarbonate</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Methyldopa, Phenytoin and Carbamazepine</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use may increase risk of toxic effects of these drugs</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor patients closely for symptoms of toxicity of methyldopa, phenytoin, and carbamazepine.</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Iodide Preparations</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use may produce hypothyroidism.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor patients for signs or symptoms of hypothyroidism <content stylecode="italics">[see Warnings and Precautions (5.7)].</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> potassium iodide</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Calcium Channel Blocking Agents (CCB)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Concomitant use may increase the risk of neurologic adverse reactions in the form of ataxia, tremors, nausea, vomiting, diarrhea and/or tinnitus.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor for neurologic adverse reactions.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> diltiazem, nifedipine, verapamil</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Atypical and Typical Antipsychotic Drugs</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Reports of neurotoxic reactions in patients treated with both lithium and an antipsychotic, ranging from extrapyramidal symptoms to neuroleptic malignant syndrome, as well as reports of an encephalopathic syndrome in few patients treated with concomitant therapy <content stylecode="italics">[see Warnings and Precautions (5.5)]</content>.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor for neurologic adverse reactions.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> risperidone, haloperidol, thioridazine, fluphenazine, chlorpromazine, perphenazine, clozapine</td>
</tr>
<tr stylecode="Botrule">
<td colspan="2" stylecode="Lrule Rrule" valign="top"> <content stylecode="bold">Neuromuscular Blocking Agents</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Clinical Impact:</content>
</td>
<td stylecode="Rrule" valign="top"> Lithium may prolong the effects of neuromuscular blocking agents.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Intervention:</content>
</td>
<td stylecode="Rrule" valign="top"> Monitor for prolonged paralysis or toxicity.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> <content stylecode="italics">Examples:</content>
</td>
<td stylecode="Rrule" valign="top"> succinylcholine, pancuronium</td>
</tr>
</tbody>
</table>